Tanja Dudenbostel | Endocrinology | Research Excellence Award

Published on by Academic Achievements

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Research Excellence Award

Assoc. Prof. Dr. Tanja Dudenbostel | Endocrinology | Assistant Professor at University of Alabama at Birmingham | United States

Endocrinology expert Assoc. Prof. Dr. Tanja Dudenbostel is an accomplished Assistant Professor at the University of Alabama at Birmingham, United States, widely recognized for her impactful contributions to endocrine and metabolic research. Assoc. Prof. Dr. Tanja Dudenbostel completed advanced medical and academic training in endocrinology-related disciplines, forming a strong foundation for translational and clinical research. Professionally, Assoc. Prof. Dr. Tanja Dudenbostel is actively engaged in academic teaching, clinical investigation, and high-impact scientific publishing. Her research interests focus on hormonal regulation, metabolic disorders, cardiometabolic risk, and endocrine mechanisms underlying chronic diseases. Her research skills include clinical research design, data analysis, biomarker evaluation, and evidence-based endocrinology. With more than two thousand citations, an h-index of 25, and a strong i10-index, Assoc. Prof. Dr. Tanja Dudenbostel has earned notable academic recognition. In conclusion, Assoc. Prof. Dr. Tanja Dudenbostel is a leading Endocrinology scholar whose research excellence continues to advance clinical understanding and patient-centered endocrine care.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

.

Citations
2285
i10index
25

h-index
36

🟦 Citations 🟥 Documents 🟩 h-index

View Google Scholar Profile

Featured Publications

Refractory hypertension: definition, prevalence, and patient characteristics
– The Journal of Clinical Hypertension, 2012
Resistant hypertension, obstructive sleep apnoea and aldosterone
– Journal of Human Hypertension, 2012
Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure
– Hypertension, 2015
Effects of antihypertensive drugs on arterial stiffness
– Cardiology in Review, 2012
Refractory hypertension: a novel phenotype of antihypertensive treatment failure
– Hypertension, 2016
Prevalence and clinical characteristics of refractory hypertension
– Journal of the American Heart Association, 2017
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease
– Journal of Human Hypertension, 2012

Regine SITRUK WARE | Endocrinology | Best Researcher Award

Published on by Academic Achievements

Dr. Regine SITRUK WARE | Endocrinology | Best Researcher Award

Dr.Regine SITRUK WARE, Population Council, United States

Dr. Regine Sitruk-Ware is a prominent researcher affiliated with the Population Council in the United States. She has made significant contributions to the fields of reproductive health and contraception, particularly in the development of innovative contraceptive technologies. Her work focuses on advancing women’s health through the introduction of safe and effective contraceptive methods. Sitruk-Ware’s research has been instrumental in shaping global reproductive health policies and practices, addressing critical issues such as family planning and women’s empowerment worldwide.

Profile

Scopus

Education🎓

Paris University, Medical School, France,M.D., 1975, Medicine (Silver Medal),Specialist, 1976, Internal Medicine,Specialist, 1981, Reproductive Endocrinology 

Experience🏫

Dr. RéGINE SITRUK-WARE currently serves as a Distinguished Scientist at the Population Council in New York, NY, where she has been pivotal in advancing reproductive health research and development. Her career spans roles in academia, industry, and international organizations, focusing on reproductive endocrinology and drug development.

Industry and International Roles 

Head of International Medical Affairs, Ciba-Geigy, Basle, Switzerland (1989-1995),Head of Research and Development, Theramex, Monaco (1995-1997),Head of Medicine, Research & Development, Exelgyn, Paris, France (1997-2000),Executive Director Research & Development, Population Council, New York, NY (2000-2010),Distinguished Scientist, Population Council, New York, NY (2010-present)

Skills

Dr. Sitrak-Ware’s expertise spans preclinical and clinical research, drug safety, and the development of reproductive health technologies. She has a strong background in leading multidisciplinary teams and managing international collaborations in the pharmaceutical and academic sectors.

Research Focus

Dr. Sitrak-Ware’s research focuses on:,Development of novel contraceptive technologies, including non-surgical permanent contraception.,Pharmacology and therapeutic potential of progestins, particularly in neuroprotection and myelin repair.,Non-oral delivery systems for hormonal therapies and contraceptives.

Publications

Dr. Sitrak-Ware has published extensively in peer-reviewed journals, contributing significant findings to the fields of reproductive endocrinology, contraceptive technologies, and pharmacology. Selected publications include:

  • Chen S, Kumar N, Mao Z, Sitruk-Ware R, Brinton RD. Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain. Menopause. 2018;25(10):1138-1151.
  • El-Etr M, Rame M, Boucher C, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions. Glia. 2015;63(1):104-117.
  • Gemzell-Danielsson K, Sitruk-Ware R, Creinin MD, et al. Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation. Contraception. 2019;99(6):323-328.
  • Brache V, Vieira CS, Plagianos M, et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study. Contraception. 2021;104(4):327-336.